Clin Endosc > Volume 45(3); 2012 > Article
Kahaleh: Endoscopic Necrosectomy for Walled-Off Pancreatic Necrosis

Abstract

Approximately 20% of patients with acute pancreatitis develop pancreatic necrosis with significant mortality. Surgical debridement is the traditional management of necrotizing pancreatitis, but it is associated with significant morbidity and mortality. Endoscopic necrosectomy using repeats session of debridement and stent insertion has been more frequently used within the last decade and half. This technique continues to evolve as we attempt to optimize the post-procedural outcomes.

INTRODUCTION

Approximately 20% of patients with acute pancreatitis develop pancreatic necrosis, and mortality rates up to 39% have been reported.1 Surgical debridement is the traditional management of necrotizing pancreatitis.1-5 However, it is associated with significant morbidity and mortality of up to 92% and 56%, respectively.6-18 Image-guided percutaneous techniques have emerged as alternative effective therapeutic options19-24 but require an indwelling catheter for an extended period of time and multiple sessions for drainage. It can also be complicated by stent lumen occlusion, secondary infections, and fistula formation.25-28 Endoscopic necrosectomy using repeats session of debridement and plastic stents insertion has been more frequently used within the last decade and half. It offers a non-invasive way to treat patients with a severe disease.
By contrast, fully covered self-expandable metallic stents might provide a safer and more efficient platform for internal drainage through a larger diameter stent.29-33 Antillon et al.34 reported the first case of transgastric endoscopic necrosectomy using a metallic esophageal stent for the treatment of infective pancreatic necrosis with successful response. Thus, this alternative approach could potentially be safer and more efficient when compared to conventional necrosectomy with plastic stents in the future.

TECHNIQUE

Using a linear array echoendoscope (GF-UCT 140-180; Olympus America, Center Valley, PA, USA), the region of pancreatic necrosis is first located. Color Doppler ultrasound is used to identify surrounding vasculature. Drainage can be attained using the Seldinger technique. Specifically, a needle knife (Boston Scientific, Natick, MA, USA) or 19 gauge fine needle aspiration needle (Wilson-Cook, Winston Salem, NC, USA) is used to obtain transenteric access into the pancreatic necrosis, creating a fistula. Once access was secured, fluid is aspirated for microbiology analysis. A 0.035 inch guidewire was advanced through the needle and coiled into the cavity. Contrast injection of the necrotic cavity can be done under fluoroscopy at the discretion of the endoscopist. Dilation of the fistula is then performed using a CRE balloon of 15 mm (Boston Scientific). Once the fistula is dilated, this provides access for active endoscopic irrigation with a standard gastroscope (Olympus America) and debridement of cystic contents using biopsy forceps, Roth nets and polypectomy snares. Debridement can be repeated for several sessions until the necrotic debris are removed. Occasionally, a nasocystic drain can be placed to irrigate the fluid collection (1 L normal saline/ 24 hours). At the end of the procedure, multiple plastic stents can be placed to keep the fistula open, or alternatively a large esophageal covered metal stent.
For patients requiring nutritional support, Percutaneous endoscopic gastrostomy with jejunal arm extension (PEG-J) is typically placed. Briefly after placing a 24 Fr PEG (Boston Scientific) facing the pylorus using the pull-through technique, a 90 cm jejunal arm was placed into the jejunum under fluoroscopic guidance. In those patients receiving PEG-J, the gastric port was connected to low wall suction and the necrosis irrigated with normal saline via the nasocystic drain to lavage the necrosis and expedite its resolution.

DISCUSSION

Although acute pancreatitis in the majority of patients is a self-limited disease, up to one third may have severe pancreatic necrosis. Infection is one of the most serious complications of pancreatic necrosis, and open necrosectomy with post-operative irrigation was conventionally the standard method of treatment. However, increasing morbidity and mortality rates prompted a search for alternative methods of minimally invasive treatments such as placement of percutaneous large-bore catheters by interventional radiologists, percutaneous necrosectomy using sinus tract endoscopy, percutaneous laparoscopic necrosectomy, and endoscopic transmural necrosectomy. This continuum of evolving invasive necrosectomy shares the common goal of avoiding laparotomy. Disadvantages of the percutaneous methods such as the indwelling catheter serving as a nidus for infection and a significant rate percutaneous fistula formation have led to the emergence of endoscopic approach.
From the initial pioneering work of Wiersema35 and Binmoeller and Soehendra36 in 1990's on endoscopic transmural drainage of pancreatic pseudocysts, this has now been established as the mainstay of treatment. In 2006, Antillon et al.37 conducted a prospective cohort study with 33 patients and demonstrated that single step endoscopic ultrasonography (EUS)-assisted transmural drainage with a large endoprosthesis was a safe and effective therapy for both simple and complicated pancreatic pseudocysts. Kruger et al.29 also reported a similar cyst resolution rate. Most recently, Bakker et al.38 of the Dutch Pancreatitis Study Group randomized 22 patients to endoscopic transgastric or surgical necrosectomy. Endoscopic transgastric necrosectomy reduced post-procedural interleukin-2 and was associated with fewer episodes of pancreatic fistulas and multiple organ failure.38 Seewald et al.39 showed that endoscopic drainage of pancreatic fluid collections (PFCs) is not only safe and effective immediately, but is also successful in the long term (72%).
The growing advances in endoscopic instrumentation resulted in a significant expansion of the management of pancreatic necrosis. However, with pancreatic necrosis there was an added need to evacuate the solid debris, which made it more challenging than pseudocyst. Hookey et al.40 in 2006 reported a success rate of 90.6% in patients who underwent EUS guided transmural drainage for patients with acute fluid collection secondary to necrosis, acute pseudocysts, chronic pseudocysts, and pancreatic abscesses. This data suggests that with the evolution of EUS, indications for transmural drainage has now expanded to include pancreatic abscesses, organized liquefied necrosis, and non-bulging PFCs. Further, direct sonographic visualization of pancreatic necrosis allows for safer transmural drainage in patients with a high-risk of bleeding, such as those with portal hypertension and coagulopathy.
Studies show that the placement of larger diameter or multiple stents would facilitate resolution in PFCs with significant debris since conventional plastic stents were limited to 10 Fr. Metal stents with larger diameter have an increased patency and decreased overall cost due to reduction in the frequency of endoscopic interventions, and have been proven to be superior to plastic stents in malignant biliary obstruction. Even though they have a high initial cost, the overall cost is reduced by decreased need for endoscopic interventions, tempting us to use them in PFCs. In 2008, Talreja et al.33 published a prospective case series of 18 patients to demonstrate the efficacy and safety of transenteric drainage by PFCs using covered self-expanding metal stent (CSEMS). Their findings confirm the decreased time required for resolution of the PFCs due to larger diameter access fistula for drainage. In addition, the use of metal stents is advantageous because they provide a radial force that can tamponade bleeding vessels within the wall of the PFC, particular stents might better appose the PFC wall to the stomach wall, and they provide better drainage.
Esophageal metallic stents are larger diameter CSEMS used primarily for palliation in malignant dysphagia. In 2009, Antillon et al.34 first described their use in a patient with infected pancreatic necrosis who refused surgery and failed four endoscopic sessions with plastic stents. The patient did well with quick resolution of pancreatitis.

CONCLUSIONS

Over the last two decades, transluminal endoscopic necrosectomy has become the mainstay of treatment for infected PFCs. This technique continues to evolve as we attempt to optimize the post-procedural outcomes. In the future, we need randomized controlled trials to compare plastic stents to larger metallic stents in this patient population.

NOTES

The author has no financial conflicts of interest.

References

1. Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379–2400. 17032204.
crossref pmid
2. Baillie J. Pancreatic pseudocysts (Part II). Gastrointest Endosc 2004;60:105–113. 15229441.
crossref pmid
3. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248–257. 9339931.
crossref pmid pmc
4. Arvanitakis M, Delhaye M, Chamlou R, et al. Endoscopic therapy for main pancreatic-duct rupture after Silastic-ring vertical gastroplasty. Gastrointest Endosc 2005;62:143–151. 15990839.
crossref pmid
5. Bradley EL, Clements JL Jr, Gonzalez AC. The natural history of pancreatic pseudocysts: a unified concept of management. Am J Surg 1979;137:135–141. 758840.
crossref pmid
6. Warshaw AL, Rattner DW. Timing of surgical drainage for pancreatic pseudocyst: clinical and chemical criteria. Ann Surg 1985;202:720–724. 4073984.
crossref pmid pmc
7. Bradley EL 3rd. A fifteen year experience with open drainage for infected pancreatic necrosis. Surg Gynecol Obstet 1993;177:215–222. 8356492.
crossref pmid
8. Boerma D, van Gulik TM, Obertop H, Gouma DJ. Internal drainage of infected pancreatic pseudocysts: safe or sorry? Dig Surg 1999;16:501–505. 10805550.
crossref pmid
9. Fernández-del Castillo C, Rattner DW, Makary MA, Mostafavi A, McGrath D, Warshaw AL. Débridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 1998;228:676–684. 9833806.
crossref pmid pmc
10. Nieuwenhuijs VB, Besselink MG, van Minnen LP, Gooszen HG. Surgical management of acute necrotizing pancreatitis: a 13-year experience and a systematic review. Scand J Gastroenterol Suppl 2003;(239):111–116. 14743893.
crossref pmid
11. Beger HG, Büchler M, Bittner R, Block S, Nevalainen T, Roscher R. Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 1988;75:207–212. 3349326.
crossref pmid
12. Farkas G, Márton J, Mándi Y, Leindler L. Surgical management and complex treatment of infected pancreatic necrosis: 18-year experience at a single center. J Gastrointest Surg 2006;10:278–285. 16455462.
crossref pmid
13. Connor S, Alexakis N, Raraty MG, et al. Early and late complications after pancreatic necrosectomy. Surgery 2005;137:499–505. 15855920.
crossref pmid
14. Rodriguez JR, Razo AO, Targarona J, et al. Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg 2008;247:294–299. 18216536.
crossref pmid pmc
15. Buchler MW, Gloor B, Müller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000;232:619–626. 11066131.
crossref pmid pmc
16. Branum G, Galloway J, Hirchowitz W, Fendley M, Hunter J. Pancreatic necrosis: results of necrosectomy, packing, and ultimate closure over drains. Ann Surg 1998;227:870–877. 9637550.
crossref pmid pmc
17. Besselink MG, de Bruijn MT, Rutten JP, Boermeester MA, Hofker HS, Gooszen HG. Surgical intervention in patients with necrotizing pancreatitis. Br J Surg 2006;93:593–599. 16521173.
crossref pmid
18. Besselink MG, Verwer TJ, Schoenmaeckers EJ, et al. Timing of surgical intervention in necrotizing pancreatitis. Arch Surg 2007;142:1194–1201. 18086987.
crossref pmid
19. vanSonnenberg E, Wittich GR, Casola G, et al. Percutaneous drainage of infected and noninfected pancreatic pseudocysts: experience in 101 cases. Radiology 1989;170(3 Pt 1):757–761. 2644662.
crossref pmid
20. Slavin J, Ghaneh P, Sutton R, et al. Management of necrotizing pancreatitis. World J Gastroenterol 2001;7:476–481. 11819813.
crossref pmid pmc
21. Freeny PC, Hauptmann E, Althaus SJ, Traverso LW, Sinanan M. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. AJR Am J Roentgenol 1998;170:969–975. 9530046.
crossref pmid
22. Gmeinwieser J, Holstege A, Zirngibl H, et al. Successful percutaneous treatment of infected necrosis of the body of the pancreas associated with segmental disruption of the main pancreatic duct. Gastrointest Endosc 2000;52:413–415. 10968863.
crossref pmid
23. Endlicher E, Völk M, Feuerbach S, Schölmerich J, Schäffler A, Messmann H. Long-term follow-up of patients with necrotizing pancreatitis treated by percutaneous necrosectomy. Hepatogastroenterology 2003;50:2225–2228. 14696503.
pmid
24. Echenique AM, Sleeman D, Yrizarry J, et al. Percutaneous catheter-directed debridement of infected pancreatic necrosis: results in 20 patients. J Vasc Interv Radiol 1998;9:565–571. 9684824.
crossref pmid
25. Ahearne PM, Baillie JM, Cotton PB, Baker ME, Meyers WC, Pappas TN. An endoscopic retrograde cholangiopancreatography (ERCP)-based algorithm for the management of pancreatic pseudocysts. Am J Surg 1992;163:111–115. 1733357.
crossref pmid
26. Adams DB, Harvey TS, Anderson MC. Percutaneous catheter drainage of infected pancreatic and peripancreatic fluid collections. Arch Surg 1990;125:1554–1557. 2244807.
crossref pmid
27. Neff R. Pancreatic pseudocysts and fluid collections: percutaneous approaches. Surg Clin North Am 2001;81:399–403. 11392426.
crossref pmid
28. Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 2000;232:175–180. 10903593.
crossref pmid pmc
29. Kruger M, Schneider AS, Manns MP, Meier PN. Endoscopic management of pancreatic pseudocysts or abscesses after an EUS-guided 1-step procedure for initial access. Gastrointest Endosc 2006;63:409–416. 16500388.
crossref pmid
30. Lopes CV, Pesenti C, Bories E, Caillol F, Giovannini M. Endoscopic-ultrasound-guided endoscopic transmural drainage of pancreatic pseudocysts and abscesses. Scand J Gastroenterol 2007;42:524–529. 17454865.
crossref pmid
31. Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006;63:986–995. 16733114.
crossref pmid
32. Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003;57:178–182. 12556780.
crossref pmid
33. Talreja JP, Shami VM, Ku J, Morris TD, Ellen K, Kahaleh M. Transenteric drainage of pancreatic-fluid collections with fully covered self-expanding metallic stents (with video). Gastrointest Endosc 2008;68:1199–1203. 19028232.
crossref pmid
34. Antillon MR, Bechtold ML, Bartalos CR, Marshall JB. Transgastric endoscopic necrosectomy with temporary metallic esophageal stent placement for the treatment of infected pancreatic necrosis (with video). Gastrointest Endosc 2009;69:178–180. 18582877.
crossref pmid
35. Wiersema MJ. Endosonography-guided cystoduodenostomy with a therapeutic ultrasound endoscope. Gastrointest Endosc 1996;44:614–617. 8934175.
crossref pmid
36. Binmoeller KF, Soehendra N. Endoscopic ultrasonography in the diagnosis and treatment of pancreatic pseudocysts. Gastrointest Endosc Clin N Am 1995;5:805–816. 8535629.
crossref pmid
37. Antillon MR, Shah RJ, Stiegmann G, Chen YK. Single-step EUS-guided transmural drainage of simple and complicated pancreatic pseudocysts. Gastrointest Endosc 2006;63:797–803. 16650541.
crossref pmid
38. Bakker OJ, van Santvoort HC, van Brunschot S, et al. Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. JAMA 2012;307:1053–1061. 22416101.
crossref pmid
39. Seewald S, Ang TL, Richter H, et al. Long-term results after endoscopic drainage and necrosectomy of symptomatic pancreatic fluid collections. Dig Endosc 2012;24:36–41. 22211410.
crossref pmid
40. Hookey LC, Debroux S, Delhaye M, Arvanitakis M, Le Moine O, Devière J. Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc 2006;63:635–643. 16564865.
crossref pmid
TOOLS
PDF Links  PDF Links
PubReader  PubReader
ePub Link  ePub Link
XML Download  XML Download
Full text via DOI  Full text via DOI
Download Citation  Download Citation
  Print
Share:      
METRICS
3
Crossref
4
Scopus
5,534
View
44
Download
Related articles
Endoscopic treatment for rectal neuroendocrine tumor: which method is better?  2022 July;55(4)
Endoscopic Ultrasound-Guided Local Therapy for Pancreatic Neoplasms  2020 September;53(5)
Endoscopic Transmural Necrosectomy: Timing, Indications, and Methods  2020 January;53(1)
Endoscopic Therapy for Acute Diverticular Bleeding  2019 September;52(5)
Endoscopic Ultrasonography for Vascular Invasion in Pancreatic Cancer  2019 September;52(5)
Editorial Office
Korean Society of Gastrointestinal Endoscopy
#817, 156 Yanghwa-ro (LG Palace, Donggyo-dong), Mapo-gu, Seoul, 04050, Korea
TEL: +82-2-335-1552   FAX: +82-2-335-2690    E-mail: CE@gie.or.kr
Copyright © Korean Society of Gastrointestinal Endoscopy.                 Developed in M2PI
Close layer